Hu, Y., Gao, S., Lu, H., & Ying, J. Y. (2022). Acid-Resistant and Physiological pH-Responsive DNA Hydrogel Composed of A-Motif and i-Motif toward Oral Insulin Delivery. Journal of the American Chemical Society, 144(12), 5461–5470. https://doi.org/10.1021/jacs.1c13426
Abstract:
An acid-resistant DNA hydrogel that is stable in an extremely acidic environment with pH as low as 1.2 has not been reported before, largely due to the instability of DNA-hybridized structures. To achieve this, adenine (A)-rich and cytosine (C)-rich oligonucleotides are rationally designed and integrated to form copolymers with acrylamide monomers via free-radical polymerization. In an acidic environment (pH 1.2–6.0), the generated copolymers form a hydrogel state, which is cross-linked by parallel A-motif duplex configurations (pH 1.2–3.0) and quadruplex i-motif structures (pH 4.0–6.0) due to the protonation of A and C bases, respectively. Specifically, the protonated A-rich sequences under pH 1.2–3.0 form a stable parallel A-motif duplex cross-linking unit through reverse Hoogsteen interaction and electrostatic attraction. Hemi-protonated C bases under mildly acidic pH (4.0–6.0) form quadruplex i-motif cross-linking configuration via Hoogsteen interaction. Under physiological pH, both A and C bases deprotonated, resulting in the separation of A-motif and i-motif to A-rich and C-rich single strands, respectively, and thereby the dissociation of the DNA hydrogel into the solution state. The acid-resistant and physiological pH-responsive DNA hydrogel was further developed for oral drug delivery to the hostile acidic environment in the stomach (pH 1.2), duodenum (pH 5.0), and small intestine (pH 7.2), where the drug would be released and absorbed. As a proof of concept, insulin was encapsulated in the DNA hydrogel and orally administered to diabetic rats. In vitro and in vivo studies demonstrated the potential usage of the DNA hydrogel for oral drug delivery.
License type:
Publisher Copyright
Funding Info:
This research / project is supported by the A*STAR - Career Development Fund (CDF)
Grant Reference no. : C210112014
This research is supported by core funding from: NanoBio Lab (Biomedical Research Council, A*STAR), and the Institute of Materials Research and Engineering (IMRE) (Science and Engineering Research Council, A*STAR)
Grant Reference no. : NA